Tech Company Financing Transactions

Interline Therapeutics Funding Round

Arch Venture Partners, Foresite Capital and private investors participated in a $92 million funding round for Interline Therapeutics. The round was announced on 5/14/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

290 Utah Ave. 300
San Francisco, CA 94080
USA

Phone

Undisclosed

Website

www.interlinetx.com

Email Address

[email protected]

Overview

Interline Therapeutics is a drug discovery company focused on systematically elucidating protein communities to define molecular mechanisms of disease. Interline is developing a precision medicine platform to map and modulate protein communities, leveraging recent advancements in genomics, proteomics, structural biology and computational chemistry.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

James Tananbaum

        

Chief Executive Officer

Zachary Sweeney

        

Browse more venture capital transactions:

Prev: 5/14/2021: Query.AI venture capital transaction
Next: 5/14/2021: Curio Entertainment venture capital transaction

Share this article

Where The Data Comes From

We do our best to document funding rounds that are announced publicly. VC transactions on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary